Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) EBITDA Margin (2016)

Historic EBITDA Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5737.96%.

  • Microbot Medical's EBITDA Margin rose 212345800.0% to 5737.96% in Q3 2016 from the same period last year, while for Sep 2016 it was 25453.42%, marking a year-over-year decrease of 215457100.0%. This contributed to the annual value of 31415.32% for FY2015, which is N/A changed from last year.
  • As of Q3 2016, Microbot Medical's EBITDA Margin stood at 5737.96%, which was up 212345800.0% from 30309.28% recorded in Q2 2016.
  • Microbot Medical's 5-year EBITDA Margin high stood at 826.99% for Q1 2012, and its period low was 42674.62% during Q1 2015.
  • In the last 5 years, Microbot Medical's EBITDA Margin had a median value of 18852.32% in 2013 and averaged 18705.6%.
  • As far as peak fluctuations go, Microbot Medical's EBITDA Margin crashed by -282068700bps in 2015, and later soared by 212345800bps in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's EBITDA Margin stood at 2917.39% in 2012, then plummeted by -582bps to 19907.16% in 2013, then soared by 94bps to 1101.83% in 2014, then tumbled by -2560bps to 29308.7% in 2015, then surged by 80bps to 5737.96% in 2016.
  • Its last three reported values are 5737.96% in Q3 2016, 30309.28% for Q2 2016, and 42366.93% during Q1 2016.